Dupilumab (Dupixent), a fully human monoclonal antibody that targets the interleukin (IL)-4 and IL-13 pathways, is currently ...

Incyte INCY suffered a setback in its ongoing mid-stage study on MRGPRX2 (INCB000262) in chronic spontaneous urticaria (CSU).

William Blair analysts led by Matt Phipps, who rate Incyte at Outperform, called the news disappointing. They highlighted ...

Nvidia helped pull U.S. stock indexes higher after they stumbled in the morning on worries about escalations in the ...

The company paused testing of one candidate acquired in its April deal for Escient and scrapped another in a blow to its ...

GSA Capital Partners LLP increased its stake in Allakos Inc. (NASDAQ:ALLK – Free Report) by 11.9% in the 3rd quarter, ...

Casirivimab and imdevimab in combination is safe among pediatric outpatients with at least 1 risk factor for severe COVID-19.

SOUTH SAN FRANCISCO, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug ...

Amcor slipped 0.3 per cent. Loading Incyte tumbled 11.1 per cent after the biopharmaceutical company said it’s pausing ...

KRIS AQUINO - The former host-actress recently shared the health scare she and her sons encountered that caused them to freak ...